EWCZ - NASDAQ
European Wax Center, Inc.
$5.82
+0.0000%European Wax Center, Inc. operates as the franchisor and operator of out-of-home waxing services in the United States. The company offers body and facial waxing services; and pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers, and skin treatments. As of March 26, 2022, it had a portfolio of centers operating in 874 locations across 44 states, including 868 franchised centers and six corporate-owned centers. European Wax Center, Inc. was founded in 2004 and is headquartered in Plano, Texas.
At a Glance
Live Snapshotewcz
Net Income
Last Annual Value
8.56M
3-Year CAGR
-1%
5-Year CAGR
3%
10-Year CAGR
9%
European Wax Center, Inc. Competitors Analysis of Net Income
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
European Wax Center, Inc. NASDAQ:EWCZ | 8.56M | -0.6% | 4.4% | N/A | |
 Alico, Inc. NASDAQ:ALCO | -147.33M | N/A | N/A | N/A | |
 Chegg, Inc. NYSE:CHGG | -103.42M | N/A | N/A | N/A | |
 Zevia PBC NYSE:ZVIA | -10.08M | N/A | N/A | N/A | |
 Legacy Education Inc. AMEX:LGCY | 7.53M | 13.8% | 26.4% | N/A | |
 Nature's Sunshine Products, Inc. NASDAQ:NATR | 19.52M | 9.0% | -7.5% | 24.7% | |
 The Beauty Health Company NASDAQ:SKIN | -9.50M | N/A | N/A | N/A | |
 Solesence, Inc. Common Stock NASDAQ:SLSN | 1.79M | N/A | -5.1% | N/A | |
 Acme United Corporation AMEX:ACU | 10.19M | -17.0% | -5.7% | 5.7% | |
 FitLife Brands, Inc. NASDAQ:FTLF | 6.33M | 6.1% | 3.2% | 32.9% |
European Wax Center, Inc. Fair Value Envelope
Related Guides
Continue your EWCZ research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.